Acute Hypoxemic Respiratory Failure: Clinical Trials

4 trials for Acute Hypoxemic Respiratory Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 1, Unknown 1
Phase 31Unknown 1

Follow Acute Hypoxemic Respiratory Failure: new trials by email Literature Review of Acute Hypoxemic Respiratory Failure trials Research Report on Acute Hypoxemic Respiratory Failure

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
Tocilizumab (Actemra®), Dexamethasone - Acute Hypoxemic Respiratory Failure
Phase 2RecruitingLorenzo delSorbo602025-10-202026-10-09
Intravenous L-Citrulline Influence on the Need for Invasive Mechanical Ventilation for Acute Hypoxemic Respiratory Failure in Patients With COVID-19
L-Citrulline, Placebo - Acute Hypoxemic Respiratory Failure
Phase 2CompletedAsklepion Pharmaceuticals, LLC652020-10-152023-02-22
Comparison Between High-flow Nasal Cannula System and Non-invasive Ventilation in Acute Hypoxemic Respiratory Failure
Non-invasive ventilation, High flow nasal cannula system - Acute Hypoxemic Respiratory Failure
Phase 2 / Phase 3UnknownAsan Medical Center742010-07-012010-07-21
Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old
Lucinactant, Sham Comparator - Acute Hypoxemic Respiratory Failure
Phase 2CompletedWindtree Therapeutics1652007-06-012012-05-03

Narrower conditions

Respiratory Insufficiency (4)

Broader conditions

Respiration Disorders (4)  ·  Respiratory Tract Diseases (4)

Interventions

Citrulline (1)  ·  Dexamethasone (1)  ·  Noninvasive Ventilation (1)  ·  Surface-Active Agents (1)  ·  lucinactant (1)  ·  serum P-component (1)  ·  tocilizumab (1)

Sponsors

Asan Medical Center (1)  ·  Asklepion Pharmaceuticals, LLC (1)  ·  Lorenzo delSorbo (1)  ·  Windtree Therapeutics (1)

Countries

United States (2)  ·  Canada (1)  ·  Chile (1)  ·  South Korea (1)

Top investigators

Adrienne Randolph, MD (1)  ·  Chae-Man Lim, M.D. (1)  ·  Gurdyal Kalsi, MD, MFPM (1)  ·  Neal Thomas, MD (1)

Results publications

PMID 22791092